Prosecution Insights
Last updated: May 29, 2026

Miltenyi Biotec B.V. & Co. KG

10 pending office actions • 7 art units • 10 examiners • 0 of 10 (0%) have an AI response strategy ready • 11 patents granted in the last 365 days

Portfolio Summary

10
Total Pending OAs
7
Non-Final OAs
3
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 10 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

6
Overdue
0
Due this week
1
Due this month
3
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 10 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (6)Due ≤ 30 days (1)Due ≤ 60 days (3)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
7
Medium (70%)
2
Easy (20%)
1
Unknown (10%)

Rejection Statute Mix

BucketCases
§103 only6 (60%)
§102 only1 (10%)
§112 only2 (20%)
No statute on record1 (10%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

10
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

100 h
Manual time on pending OAs
20 h
Time saved (low, 20%)
35 h
Time saved (mid, 35%)
0.9 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
STONEBRAKER, ALYSSA RAE 1 54.4% +52.8%
OGUNTADE, ELIZABETH BISOLA 1 0.0% +0.0%
LUNDE, GRACE HENRY 1 63.6% +37.5%
GAO, ASHLEY HARTMAN 1 59.8% +38.9%
GRAY, JESSICA 1 0.0% +0.0%
HAQ, SHAFIQUL 1 64.8% +55.5%
CALAMITA, HEATHER 1 37.8% +9.4%
TURPIN, ZACHARY MARK 1 0.0% +0.0%
CASH, KAILEY ELIZABETH 1 28.6% +48.9%
VOLKOV, ALEXANDER ALEXANDROVIC 1 27.7% +22.9%

Hard Cases (5)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
17751952 SPATIAL SEQUENCING WITH MICTAG TURPIN, ZACHARY MARK 79d overdue
17771591 COLOR AND BARCODED BEADS FOR SINGLE CELL INDEXING CASH, KAILEY ELIZABETH 32d overdue
18280706 ARTIFICIAL TARGET FOR ANTIGEN-SPECIFIC ACTIVATION AND EXPANSION OF CAR T CELLS OGUNTADE, ELIZABETH BISOLA 9d
17986357 SEQUENCING OF DNA BY SEQUENTIAL ADDITION/INCORPORATION OF 3` UNPROTECTED LABELED NUCLEOTIDES GRAY, JESSICA 34d
17626515 ASSAY FOR IDENTIFYING COLONY-FORMING CELLS VOLKOV, ALEXANDER ALEXANDROVIC 39d

Interview Candidates (6)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
18033335 CHIMERIC ANTIGEN RECEPTOR COMPRISING AN ANTIGEN BINDING DOMAIN SPECIFIC FOR MSLN HAVING A SPECIFICITY FOR TUMOR CELLS LUNDE, GRACE HENRY 78d overdue
18471357 Chimeric Antigen Receptor Specific for Folate Receptor 1 STONEBRAKER, ALYSSA RAE 45d overdue
17771591 COLOR AND BARCODED BEADS FOR SINGLE CELL INDEXING CASH, KAILEY ELIZABETH 32d overdue
18024603 CONJUGATES HAVING AN ENZYMMATICALLY RELEASABLE DETECTION MOIETY AND A BARCODE MOIETY GAO, ASHLEY HARTMAN 17d overdue
17626515 ASSAY FOR IDENTIFYING COLONY-FORMING CELLS VOLKOV, ALEXANDER ALEXANDROVIC 39d
17976933 BRIGHT AND RELEASABLE LABELS FOR CELL STAINING BASED ON THE CONJUGATES WITH SEVERAL SITES OF FLUOROPHORE RELEASE HAQ, SHAFIQUL 56d

Top Art Units

Art UnitApps
1677 2
1678 2
1682 2
1642 1
1641 1
1684 1
1683 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18471357 Chimeric Antigen Receptor Specific for Folate Receptor 1 STONEBRAKER, ALYSSA RAE 1642 §103 Non-Final OA 45d overdue Pending Sep 21, 2023
18280706 ARTIFICIAL TARGET FOR ANTIGEN-SPECIFIC ACTIVATION AND EXPANSION OF CAR T CELLS OGUNTADE, ELIZABETH BISOLA 1677 §103 Non-Final OA 9d Pending Sep 07, 2023
18033335 CHIMERIC ANTIGEN RECEPTOR COMPRISING AN ANTIGEN BINDING DOMAIN SPECIFIC FOR MSLN HAVING A SPECIFICITY FOR TUMOR CELLS LUNDE, GRACE HENRY 1641 §103 Non-Final OA 78d overdue Pending Apr 22, 2023
18024603 CONJUGATES HAVING AN ENZYMMATICALLY RELEASABLE DETECTION MOIETY AND A BARCODE MOIETY GAO, ASHLEY HARTMAN 1678 Other Non-Final OA 17d overdue Pending Mar 03, 2023
17986357 SEQUENCING OF DNA BY SEQUENTIAL ADDITION/INCORPORATION OF 3` UNPROTECTED LABELED NUCLEOTIDES GRAY, JESSICA 1682 §103 Final Rejection 34d Pending Nov 14, 2022
17976933 BRIGHT AND RELEASABLE LABELS FOR CELL STAINING BASED ON THE CONJUGATES WITH SEVERAL SITES OF FLUOROPHORE RELEASE HAQ, SHAFIQUL 1678 §103 Non-Final OA 56d Pending Oct 31, 2022
17940032 METHOD FOR OBTAINING SPATIAL AND SEQUENCING INFORMATION OF M-RNA FROM TISSUE CALAMITA, HEATHER 1684 §103 Final Rejection 23d overdue Pending Sep 08, 2022
17751952 SPATIAL SEQUENCING WITH MICTAG TURPIN, ZACHARY MARK 1682 §112 Final Rejection 79d overdue Pending May 24, 2022
17771591 COLOR AND BARCODED BEADS FOR SINGLE CELL INDEXING CASH, KAILEY ELIZABETH 1683 §102 Non-Final OA 32d overdue Pending Apr 25, 2022
17626515 ASSAY FOR IDENTIFYING COLONY-FORMING CELLS VOLKOV, ALEXANDER ALEXANDROVIC 1677 §112 Non-Final OA 39d Pending Jan 12, 2022

Managing Miltenyi Biotec B.V. & Co. KG's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month